These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15020202)

  • 21. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton.
    Hayot C; Farinelle S; De Decker R; Decaestecker C; Darro F; Kiss R; Van Damme M
    Int J Oncol; 2002 Aug; 21(2):417-25. PubMed ID: 12118340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baicalein and baicalin are potent inhibitors of angiogenesis: Inhibition of endothelial cell proliferation, migration and differentiation.
    Liu JJ; Huang TS; Cheng WF; Lu FJ
    Int J Cancer; 2003 Sep; 106(4):559-565. PubMed ID: 12845652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generational analysis reveals that TGF-beta1 inhibits the rate of angiogenesis in vivo by selective decrease in the number of new vessels.
    Parsons-Wingerter P; Elliott KE; Farr AG; Radhakrishnan K; Clark JI; Sage EH
    Microvasc Res; 2000 Mar; 59(2):221-32. PubMed ID: 10684728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of mycophenolic acid and dexamethasone on the angiogenic activity of human umbilical vein endothelial cells].
    Huang H; Liu Z; Liu H
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):801-4. PubMed ID: 11798970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of laminin-1 in the modulation of radiation damage in endothelial cells and differentiation.
    Rose RW; Grant DS; O'Hara MD; Williamson SK
    Radiat Res; 1999 Jul; 152(1):14-28. PubMed ID: 10381837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
    Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
    Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress.
    Mezentsev A; Merks RM; O'Riordan E; Chen J; Mendelev N; Goligorsky MS; Brodsky SV
    Am J Physiol Heart Circ Physiol; 2005 Sep; 289(3):H1106-14. PubMed ID: 15879485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.
    Sweeney CJ; Miller KD; Sissons SE; Nozaki S; Heilman DK; Shen J; Sledge GW
    Cancer Res; 2001 Apr; 61(8):3369-72. PubMed ID: 11309294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutive expression of the DNA-binding domain of Ets1 increases endothelial cell adhesion and stimulates their organization into capillary-like structures.
    Mattot V; Vercamer C; Soncin F; Calmels T; Huguet C; Fafeur V; Vandenbunder B
    Oncogene; 2000 Feb; 19(6):762-72. PubMed ID: 10698494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial zinc finger 1 is involved in the regulation of angiogenesis: possible contribution of stathmin/OP18 as a downstream target gene.
    Miyashita H; Kanemura M; Yamazaki T; Abe M; Sato Y
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):878-84. PubMed ID: 15031128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electromagnetic fields increase in vitro and in vivo angiogenesis through endothelial release of FGF-2.
    Tepper OM; Callaghan MJ; Chang EI; Galiano RD; Bhatt KA; Baharestani S; Gan J; Simon B; Hopper RA; Levine JP; Gurtner GC
    FASEB J; 2004 Aug; 18(11):1231-3. PubMed ID: 15208265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo.
    Grant DS; Kinsella JL; Fridman R; Auerbach R; Piasecki BA; Yamada Y; Zain M; Kleinman HK
    J Cell Physiol; 1992 Dec; 153(3):614-25. PubMed ID: 1280280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor.
    Serratì S; Cinelli M; Margheri F; Guiducci S; Del Rosso A; Pucci M; Fibbi G; Bazzichi L; Bombardieri S; Matucci-Cerinic M; Del Rosso M
    J Pathol; 2006 Oct; 210(2):240-8. PubMed ID: 16917801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro.
    Bootle-Wilbraham CA; Tazzyman S; Marshall JM; Lewis CE
    Cancer Res; 2000 Sep; 60(17):4719-24. PubMed ID: 10987275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HUVEC/Matrigel assay: an in vivo assay of human angiogenesis suitable for drug validation.
    Skovseth DK; Küchler AM; Haraldsen G
    Methods Mol Biol; 2007; 360():253-68. PubMed ID: 17172733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
    Morais C; Gobe G; Johnson DW; Healy H
    Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid.
    Masso-Welch PA; Zangani D; Ip C; Vaughan MM; Shoemaker S; Ramirez RA; Ip MM
    Cancer Res; 2002 Aug; 62(15):4383-9. PubMed ID: 12154044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiangiogenic properties of lupulone, a bitter acid of hop cones.
    Siegel L; Miternique-Grosse A; Griffon C; Klein-Soyer C; Lobstein A; Raul F; Stephan D
    Anticancer Res; 2008; 28(1A):289-94. PubMed ID: 18383859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets.
    Albini A; Dell'Eva R; Vené R; Ferrari N; Buhler DR; Noonan DM; Fassina G
    FASEB J; 2006 Mar; 20(3):527-9. PubMed ID: 16403733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.